This may involve adjusting your GLP-1 medication
25.2 months for the PIONEER 6 and SUSTAIN-6 trials, respectively) [35,36], the HR of the PIONEER 6 study may have been statistically significant if the follow-up duration had been longer
Breaking Plateaus For patients who have stalled on other therapies, the triple-agonist mechanism provides a new metabolic stimulus to support further provider-guided evaluation after a plateau
Ask us about adding glycine to your weight loss protocol, or schedule a metabolic optimization visit today
While GLP-1 analogs suppressed genes related to fatty acid synthesis, they had no significant effect on inflammation-related gene expressions
Patients should consult their healthcare provider before adding berberine to their regimen and implement more frequent blood glucose monitoring if using both therapies